サマリー

バイオシミラーの世界市場 2023-2027
Technavioはバイオシミラー市場を監視しており、2023年から2027年の間に4億2212万ドルの成長が見込まれ、予測期間中にCAGR23%で加速しています。当レポートでは、バイオシミラー市場の全体分析、市場規模と予測、動向、成長ドライバー、課題、さらに約25社のベンダーを網羅したベンダー分析を行っています。
現在の世界市場のシナリオ、最新のトレンドとドライバー、市場全体の環境に関する最新の分析を提供しています。市場は、生物製剤に対するバイオシミラーの価格優位性、主要な生物製剤の特許切れ、バイオシミラー医薬品の使用を増やすための政府の取り組みによって牽引されています。
Technavioのバイオシミラー市場は、以下のように区分されています。
製品タイプ別
- モノクローナル抗体
- インスリン
- ヒト成長ホルモン
- その他
アプリケーション別
- 腫瘍・血液内科
- 内分泌学
- 免疫学
- 腎臓学
地域別状況
- 欧州
- 北アメリカ
- アジア
- その他の地域（ROW）
本調査では、患者や医師のバイオシミラーへの切り替え意欲が、今後数年間のバイオシミラー市場の成長を促進する主要な理由の1つであると特定しています。また、各国のバイオシミラーに対する治療互換性規制とバイオシミラーの特許ダンスは、市場の大きな需要につながるでしょう。
Technavioは、複数のソースからのデータを調査、合成、総括する方法で、主要パラメータの分析により、市場の詳細な姿を提示します。バイオシミラー市場に関する弊社のレポートは、以下の分野を対象としています。
- バイオシミラー市場のサイジング
- バイオシミラー市場の予測
- バイオシミラー市場の産業分析
Technavioの強力なベンダー分析は、お客様が市場での地位を向上できるように設計されています。これに沿って、本レポートでは、AbbVie Inc.、Amgen Inc.、Biocon Ltd.、Biogen Inc.、Boehringer Ingelheim International GmbH、Celltrion Healthcare Co.Ltd.、Dr. Reddys Laboratories Ltd.、F. Hoffmann La Roche Ltd.、Fresenius SE and Co.KGaA、Gedeon Richter Plc、Halozyme Therapeutics Inc、Intas Pharmaceuticals Ltd.、Mabion S.A.、Novartis AG、Pfizer Inc.、Samsung Biologics Co.Ltd.、Sanofi SA、Teva Pharmaceutical Industries Ltd.、Viatris Inc.の7社です。また、バイオシミラー市場の分析レポートには、今後の動向や市場成長に影響を与える課題に関する情報も含まれています。これは、企業が今後訪れるすべての成長機会を戦略的に活用するのに役立つものです。
本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報の客観的な組み合わせを使用して実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/biosimilars-market-industry-analysis をご覧ください。
Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数のソースからのデータの研究、合成、総括の方法により、市場の詳細な姿を提示します。また、業界の主要なインフルエンサーを特定することにより、市場の様々な側面を提示します。提示されるデータは、包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、定性的および定量的調査を用いた詳細なベンダー選定方法と分析を提供します。

ページTOPに戻る

目次

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary - Chart on Market Overview
o Exhibit 02: Executive Summary - Data Table on Market Overview
o Exhibit 03: Executive Summary - Chart on Global Market Characteristics
o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary - Chart on Market Segmentation by Product Type
o Exhibit 06: Executive Summary - Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary - Chart on Incremental Growth
o Exhibit 08: Executive Summary - Data Table on Incremental Growth
o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global biosimilars market 2017 - 2021
o Exhibit 18: Historic Market Size - Data Table on Global biosimilars market 2017 - 2021 ($ million)
o 4.2 Product Segment Analysis 2017 - 2021
o Exhibit 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
o 4.3 Application Segment Analysis 2017 - 2021
o Exhibit 20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 - 2021
o Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
o 4.5 Country Segment Analysis 2017 - 2021
o Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
• 6 Market Segmentation by Product Type
o 6.1 Market segments
o Exhibit 30: Chart on Product Type - Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product Type - Market share 2022-2027 (%)
o 6.2 Comparison by Product Type
o Exhibit 32: Chart on Comparison by Product Type
o Exhibit 33: Data Table on Comparison by Product Type
o 6.3 Monoclonal antibodies - Market size and forecast 2022-2027
o Exhibit 34: Chart on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
o 6.4 Insulin - Market size and forecast 2022-2027
o Exhibit 38: Chart on Insulin - Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Insulin - Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Insulin - Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
o 6.5 Human growth hormone - Market size and forecast 2022-2027
o Exhibit 42: Chart on Human growth hormone - Market size and forecast 2022-2027 ($ million)
o Exhibit 43: Data Table on Human growth hormone - Market size and forecast 2022-2027 ($ million)
o Exhibit 44: Chart on Human growth hormone - Year-over-year growth 2022-2027 (%)
o Exhibit 45: Data Table on Human growth hormone - Year-over-year growth 2022-2027 (%)
o 6.6 Others - Market size and forecast 2022-2027
o Exhibit 46: Chart on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Chart on Others - Year-over-year growth 2022-2027 (%)
o Exhibit 49: Data Table on Others - Year-over-year growth 2022-2027 (%)
o 6.7 Market opportunity by Product Type
o Exhibit 50: Market opportunity by Product Type ($ million)
• 7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 51: Chart on Application - Market share 2022-2027 (%)
o Exhibit 52: Data Table on Application - Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 53: Chart on Comparison by Application
o Exhibit 54: Data Table on Comparison by Application
o 7.3 Oncology and hematology - Market size and forecast 2022-2027
o Exhibit 55: Chart on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
o Exhibit 56: Data Table on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
o Exhibit 57: Chart on Oncology and hematology - Year-over-year growth 2022-2027 (%)
o Exhibit 58: Data Table on Oncology and hematology - Year-over-year growth 2022-2027 (%)
o 7.4 Endocrinology - Market size and forecast 2022-2027
o Exhibit 59: Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
o Exhibit 60: Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
o Exhibit 61: Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
o Exhibit 62: Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
o 7.5 Immunology - Market size and forecast 2022-2027
o Exhibit 63: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on Immunology - Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
o 7.6 Nephrology - Market size and forecast 2022-2027
o Exhibit 67: Chart on Nephrology - Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Nephrology - Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Nephrology - Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Nephrology - Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 71: Market opportunity by Application ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 73: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 75: Chart on Geographic comparison
o Exhibit 76: Data Table on Geographic comparison
o 9.3 Europe - Market size and forecast 2022-2027
o Exhibit 77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on Europe - Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
o 9.4 North America - Market size and forecast 2022-2027
o Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
o 9.5 Asia - Market size and forecast 2022-2027
o Exhibit 85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Asia - Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
o Exhibit 89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
o 9.7 Germany - Market size and forecast 2022-2027
o Exhibit 93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on Germany - Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
o 9.8 US - Market size and forecast 2022-2027
o Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
o Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
o Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
o 9.9 UK - Market size and forecast 2022-2027
o Exhibit 101: Chart on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
o Exhibit 103: Chart on UK - Year-over-year growth 2022-2027 (%)
o Exhibit 104: Data Table on UK - Year-over-year growth 2022-2027 (%)
o 9.10 China - Market size and forecast 2022-2027
o Exhibit 105: Chart on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 106: Data Table on China - Market size and forecast 2022-2027 ($ million)
o Exhibit 107: Chart on China - Year-over-year growth 2022-2027 (%)
o Exhibit 108: Data Table on China - Year-over-year growth 2022-2027 (%)
o 9.11 Republic of Korea - Market size and forecast 2022-2027
o Exhibit 109: Chart on Republic of Korea - Market size and forecast 2022-2027 ($ million)
o Exhibit 110: Data Table on Republic of Korea - Market size and forecast 2022-2027 ($ million)
o Exhibit 111: Chart on Republic of Korea - Year-over-year growth 2022-2027 (%)
o Exhibit 112: Data Table on Republic of Korea - Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 113: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 114: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 115: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 116: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 117: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 118: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 119: Matrix on vendor position and classification
o 12.3 AbbVie Inc.
o Exhibit 120: AbbVie Inc. - Overview
o Exhibit 121: AbbVie Inc. - Product / Service
o Exhibit 122: AbbVie Inc. - Key offerings
o 12.4 Amgen Inc.
o Exhibit 123: Amgen Inc. - Overview
o Exhibit 124: Amgen Inc. - Product / Service
o Exhibit 125: Amgen Inc. - Key offerings
o 12.5 Biocon Ltd.
o Exhibit 126: Biocon Ltd. - Overview
o Exhibit 127: Biocon Ltd. - Business segments
o Exhibit 128: Biocon Ltd. - Key offerings
o Exhibit 129: Biocon Ltd. - Segment focus
o 12.6 Biogen Inc.
o Exhibit 130: Biogen Inc. - Overview
o Exhibit 131: Biogen Inc. - Product / Service
o Exhibit 132: Biogen Inc. - Key offerings
o 12.7 Boehringer Ingelheim International GmbH
o Exhibit 133: Boehringer Ingelheim International GmbH - Overview
o Exhibit 134: Boehringer Ingelheim International GmbH - Business segments
o Exhibit 135: Boehringer Ingelheim International GmbH - Key news
o Exhibit 136: Boehringer Ingelheim International GmbH - Key offerings
o Exhibit 137: Boehringer Ingelheim International GmbH - Segment focus
o 12.8 Celltrion Healthcare Co. Ltd.
o Exhibit 138: Celltrion Healthcare Co. Ltd. - Overview
o Exhibit 139: Celltrion Healthcare Co. Ltd. - Product / Service
o Exhibit 140: Celltrion Healthcare Co. Ltd. - Key offerings
o 12.9 Dr Reddys Laboratories Ltd.
o Exhibit 141: Dr Reddys Laboratories Ltd. - Overview
o Exhibit 142: Dr Reddys Laboratories Ltd. - Business segments
o Exhibit 143: Dr Reddys Laboratories Ltd. - Key offerings
o Exhibit 144: Dr Reddys Laboratories Ltd. - Segment focus
o 12.10 F. Hoffmann La Roche Ltd.
o Exhibit 145: F. Hoffmann La Roche Ltd. - Overview
o Exhibit 146: F. Hoffmann La Roche Ltd. - Business segments
o Exhibit 147: F. Hoffmann La Roche Ltd. - Key news
o Exhibit 148: F. Hoffmann La Roche Ltd. - Key offerings
o Exhibit 149: F. Hoffmann La Roche Ltd. - Segment focus
o 12.11 Fresenius SE and Co. KGaA
o Exhibit 150: Fresenius SE and Co. KGaA - Overview
o Exhibit 151: Fresenius SE and Co. KGaA - Business segments
o Exhibit 152: Fresenius SE and Co. KGaA - Key news
o Exhibit 153: Fresenius SE and Co. KGaA - Key offerings
o Exhibit 154: Fresenius SE and Co. KGaA - Segment focus
o 12.12 Gedeon Richter Plc
o Exhibit 155: Gedeon Richter Plc - Overview
o Exhibit 156: Gedeon Richter Plc - Business segments
o Exhibit 157: Gedeon Richter Plc - Key news
o Exhibit 158: Gedeon Richter Plc - Key offerings
o Exhibit 159: Gedeon Richter Plc - Segment focus
o 12.13 Halozyme Therapeutics Inc
o Exhibit 160: Halozyme Therapeutics Inc - Overview
o Exhibit 161: Halozyme Therapeutics Inc - Product / Service
o Exhibit 162: Halozyme Therapeutics Inc - Key offerings
o 12.14 Intas Pharmaceuticals Ltd.
o Exhibit 163: Intas Pharmaceuticals Ltd. - Overview
o Exhibit 164: Intas Pharmaceuticals Ltd. - Product / Service
o Exhibit 165: Intas Pharmaceuticals Ltd. - Key offerings
o 12.15 Mabion S.A.
o Exhibit 166: Mabion S.A. - Overview
o Exhibit 167: Mabion S.A. - Product / Service
o Exhibit 168: Mabion S.A. - Key offerings
o 12.16 Novartis AG
o Exhibit 169: Novartis AG - Overview
o Exhibit 170: Novartis AG - Business segments
o Exhibit 171: Novartis AG - Key offerings
o Exhibit 172: Novartis AG - Segment focus
o 12.17 Viatris Inc.
o Exhibit 173: Viatris Inc. - Overview
o Exhibit 174: Viatris Inc. - Business segments
o Exhibit 175: Viatris Inc. - Key offerings
o Exhibit 176: Viatris Inc. - Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations


Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size - Data Table on Global biosimilars market 2017 - 2021 ($ million)
Exhibits19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits20: Historic Market Size - Application Segment 2017 - 2021 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits23: Five forces analysis - Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition - Five forces 2022 and 2027
Exhibits30: Chart on Product Type - Market share 2022-2027 (%)
Exhibits31: Data Table on Product Type - Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product Type
Exhibits33: Data Table on Comparison by Product Type
Exhibits34: Chart on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Monoclonal antibodies - Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Monoclonal antibodies - Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Insulin - Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Insulin - Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Insulin - Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Insulin - Year-over-year growth 2022-2027 (%)
Exhibits42: Chart on Human growth hormone - Market size and forecast 2022-2027 ($ million)
Exhibits43: Data Table on Human growth hormone - Market size and forecast 2022-2027 ($ million)
Exhibits44: Chart on Human growth hormone - Year-over-year growth 2022-2027 (%)
Exhibits45: Data Table on Human growth hormone - Year-over-year growth 2022-2027 (%)
Exhibits46: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits47: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits48: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits49: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits50: Market opportunity by Product Type ($ million)
Exhibits51: Chart on Application - Market share 2022-2027 (%)
Exhibits52: Data Table on Application - Market share 2022-2027 (%)
Exhibits53: Chart on Comparison by Application
Exhibits54: Data Table on Comparison by Application
Exhibits55: Chart on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
Exhibits56: Data Table on Oncology and hematology - Market size and forecast 2022-2027 ($ million)
Exhibits57: Chart on Oncology and hematology - Year-over-year growth 2022-2027 (%)
Exhibits58: Data Table on Oncology and hematology - Year-over-year growth 2022-2027 (%)
Exhibits59: Chart on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits60: Data Table on Endocrinology - Market size and forecast 2022-2027 ($ million)
Exhibits61: Chart on Endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits62: Data Table on Endocrinology - Year-over-year growth 2022-2027 (%)
Exhibits63: Chart on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on Immunology - Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on Immunology - Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Nephrology - Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Nephrology - Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Nephrology - Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Nephrology - Year-over-year growth 2022-2027 (%)
Exhibits71: Market opportunity by Application ($ million)
Exhibits72: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits73: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits74: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits75: Chart on Geographic comparison
Exhibits76: Data Table on Geographic comparison
Exhibits77: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on Germany - Year-over-year growth 2022-2027 (%)
Exhibits97: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits98: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits99: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits100: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits101: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits102: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits103: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits104: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits105: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits106: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits107: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits108: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits109: Chart on Republic of Korea - Market size and forecast 2022-2027 ($ million)
Exhibits110: Data Table on Republic of Korea - Market size and forecast 2022-2027 ($ million)
Exhibits111: Chart on Republic of Korea - Year-over-year growth 2022-2027 (%)
Exhibits112: Data Table on Republic of Korea - Year-over-year growth 2022-2027 (%)
Exhibits113: Market opportunity By Geographical Landscape ($ million)
Exhibits114: Impact of drivers and challenges in 2022 and 2027
Exhibits115: Overview on Criticality of inputs and Factors of differentiation
Exhibits116: Overview on factors of disruption
Exhibits117: Impact of key risks on business
Exhibits118: Vendors covered
Exhibits119: Matrix on vendor position and classification
Exhibits120: AbbVie Inc. - Overview
Exhibits121: AbbVie Inc. - Product / Service
Exhibits122: AbbVie Inc. - Key offerings
Exhibits123: Amgen Inc. - Overview
Exhibits124: Amgen Inc. - Product / Service
Exhibits125: Amgen Inc. - Key offerings
Exhibits126: Biocon Ltd. - Overview
Exhibits127: Biocon Ltd. - Business segments
Exhibits128: Biocon Ltd. - Key offerings
Exhibits129: Biocon Ltd. - Segment focus
Exhibits130: Biogen Inc. - Overview
Exhibits131: Biogen Inc. - Product / Service
Exhibits132: Biogen Inc. - Key offerings
Exhibits133: Boehringer Ingelheim International GmbH - Overview
Exhibits134: Boehringer Ingelheim International GmbH - Business segments
Exhibits135: Boehringer Ingelheim International GmbH - Key news
Exhibits136: Boehringer Ingelheim International GmbH - Key offerings
Exhibits137: Boehringer Ingelheim International GmbH - Segment focus
Exhibits138: Celltrion Healthcare Co. Ltd. - Overview
Exhibits139: Celltrion Healthcare Co. Ltd. - Product / Service
Exhibits140: Celltrion Healthcare Co. Ltd. - Key offerings
Exhibits141: Dr Reddys Laboratories Ltd. - Overview
Exhibits142: Dr Reddys Laboratories Ltd. - Business segments
Exhibits143: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits144: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits145: F. Hoffmann La Roche Ltd. - Overview
Exhibits146: F. Hoffmann La Roche Ltd. - Business segments
Exhibits147: F. Hoffmann La Roche Ltd. - Key news
Exhibits148: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits149: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits150: Fresenius SE and Co. KGaA - Overview
Exhibits151: Fresenius SE and Co. KGaA - Business segments
Exhibits152: Fresenius SE and Co. KGaA - Key news
Exhibits153: Fresenius SE and Co. KGaA - Key offerings
Exhibits154: Fresenius SE and Co. KGaA - Segment focus
Exhibits155: Gedeon Richter Plc - Overview
Exhibits156: Gedeon Richter Plc - Business segments
Exhibits157: Gedeon Richter Plc - Key news
Exhibits158: Gedeon Richter Plc - Key offerings
Exhibits159: Gedeon Richter Plc - Segment focus
Exhibits160: Halozyme Therapeutics Inc - Overview
Exhibits161: Halozyme Therapeutics Inc - Product / Service
Exhibits162: Halozyme Therapeutics Inc - Key offerings
Exhibits163: Intas Pharmaceuticals Ltd. - Overview
Exhibits164: Intas Pharmaceuticals Ltd. - Product / Service
Exhibits165: Intas Pharmaceuticals Ltd. - Key offerings
Exhibits166: Mabion S.A. - Overview
Exhibits167: Mabion S.A. - Product / Service
Exhibits168: Mabion S.A. - Key offerings
Exhibits169: Novartis AG - Overview
Exhibits170: Novartis AG - Business segments
Exhibits171: Novartis AG - Key offerings
Exhibits172: Novartis AG - Segment focus
Exhibits173: Viatris Inc. - Overview
Exhibits174: Viatris Inc. - Business segments
Exhibits175: Viatris Inc. - Key offerings
Exhibits176: Viatris Inc. - Segment focus
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations